Bio Medica Laboratories Limited (NSE:BMLL)

India · Delayed Price · Currency is INR

145.35

-6.60 (-4.34%)

At close: Nov 6, 2026

Bio Medica Laboratories Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	430.9	430.9	383.2	152.49	162.28	212.25
Revenue Growth	103.01%	12.45%	151.29%	-6.03%	-23.54%	64.21%
Gross Profit	254.78	254.78	191.69	85.07	46.58	44.45
Operating Income	188.31	188.31	144.92	45.28	12.14	15.65
Net Income	117.81	117.81	97.04	26.31	3.6	5.89
Earnings Per Share	12.83	12.83	10.57	2.87	0.39	0.64
EPS Growth	1900.14%	21.41%	268.75%	631.22%	-38.90%	34.11%

Revenue by Geography

Fiscal Year	TTM	FY 2026
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026
India	418.97	418.97
Export	3.93	3.93
Unallocated	7.99	7.99
Total	430.9	430.9

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	1.04	1.04	0.07	0.1	0.06	15.28
Total Debt	399.89	399.89	150.14	104.9	96.07	109.6
Net Cash (Debt)	-398.86	-398.86	-150.08	-104.8	-96.01	-94.32
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-43.45	-43.45	-16.35	-11.42	-10.46	-10.27

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-60.35	-60.35	-45.74	-7.88	6.52	-
Capital Expenditures	-30.09	-30.09	-	-15.26	-17.1	-
Free Cash Flow	-90.44	-90.44	-45.74	-23.13	-10.58	-
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	59.13%	59.13%	50.02%	55.79%	28.70%	20.94%
Operating Margin	43.70%	43.70%	37.82%	29.69%	7.48%	7.37%
Pretax Margin	37.72%	37.72%	34.30%	23.41%	3.01%	3.76%
Profit Margin	27.34%	27.34%	25.32%	17.26%	2.22%	2.77%
FCF Margin	-20.99%	-20.99%	-11.94%	-15.17%	-6.52%	-